Adient (ADNT) Q2 2026 earnings review
Revenue Accelerates, But Mix Shift Crushes Margins
Adient delivered strong top-line growth in Q2, with revenue accelerating 7% YoY to $3.86B, breaking a streak of sluggish quarters. However, the volume recovery masked a significant deterioration in profitability. Adjusted EBITDA fell 4% to $223M, and margins compressed from 6.5% to 5.8%. The primary culprit is Asia: as Adient pivots to faster-growing domestic Chinese OEMs, segment operating margins plummeted from 15.6% to 12.5%. While GAAP net income reversed to a $27M profit (driven by the absence of last year's massive $333M impairment), underlying earnings quality is flashing warning signs, notably in free cash flow.
🐂 Bull Case
The Americas segment accelerated to 11% YoY revenue growth with margins expanding to 5.8%, validating management's strategy to capture structural reshoring volume from competitors.
The $333M goodwill impairment from last year did not repeat, and restructuring costs fell from $351M to just $5M, drastically cleaning up the GAAP income statement.
🐻 Bear Case
The highly profitable Asia segment saw margins compress 310 bps YoY to 12.5%, proving that winning business with domestic Chinese OEMs comes at a steep profitability cost.
Free Cash Flow flipped positive to $8M, but it was entirely driven by a $90M timing benefit from commercial transactions that will reverse next quarter. True cash generation is negative.
⚖️ Verdict: 🔴
Bearish. The top-line acceleration is impressive, but giving up 310 bps of margin in the historically high-margin Asia segment suggests a structural decline in earnings power as mix shifts to local OEMs.
Key Themes
Asia Margin Collapse Highlights Mix Risk
Management warned in prior quarters about margin compression as they pivoted toward domestic Chinese OEMs. This quarter, the bill came due. Asia adjusted EBITDA fell 16% YoY to $92M, and margins decelerated violently from 15.6% to 12.5%. While revenue grew 4%, the decremental margin on this mix shift is severe, effectively dragging down the entire company's profitability.
Americas segment Leading Growth
The Americas segment was the sole bright spot for profitability. Revenue surged 11% YoY to $1.88B, and Adjusted EBITDA grew 16% to $109M. Margins expanded from 5.5% to 5.8%. This solidifies the narrative from Q1 that Adient's USMCA-compliant footprint and ModuTech modular seat design are successfully capturing a $500M reshoring opportunity.
Free Cash Flow Timing Artifact
Reported Free Cash Flow reversed from -$90M a year ago to +$8M this quarter. However, a footnote directly contradicts this positive narrative: the company experienced an artificially high operating cash flow resulting from '$90 million in commercial and derivative transactions' that will be paid out in Q3. Without this artifact, underlying FCF was deeply negative at roughly -$82M, suggesting poor working capital conversion during the revenue ramp.
EMEA Margin Compression Continues
Despite spending over $130M annually on restructuring in recent years, EMEA remains a structural laggard. While revenue grew 3% to $1.27B, Adjusted EBITDA fell 10% to $45M. Margins decelerated from 4.1% a year ago to 3.5%, moving further away from management's mid-single-digit target.
Product Innovation Accelerating Market Share
The deployment of the 'ModuTech' modular seat design—which management previously claimed delivers up to 20% in value chain savings and a 15% reduction in JIT floor space—is acting as a primary driver for the recent conquest wins in the Americas. This shift from hardware-centric to highly automated, modular manufacturing is protecting the bottom line in the West.
Tax Rate Headwinds Neutralizing Operating Gains
The adjusted effective tax rate spiked significantly, decelerating from 28.9% in 25Q2 to 39.2% in 26Q2. This 1,030 bps increase consumed a large portion of operating income, dropping Adjusted Net Income by 29% to $41M, despite stable EBIT levels.
Other KPIs
Decelerating. Gross margin dropped from 7.2% in the prior year period. Cost of sales grew 7.7% YoY ($3.60B vs $3.35B), slightly outpacing the 7.0% revenue growth, reflecting the negative margin mix shift heavily concentrated in Asia.
Decelerating. Up from 1.63x at the end of FY25. LTM Adjusted EBITDA has stalled at $882M, while net debt grew to $1.55B as cash balances declined from $958M to $831M over the last six months. It remains within the 1.5x-2.0x target but is moving in the wrong direction.
Decelerating. Down from $0.69 a year ago. The drop is a combination of lower Adjusted EBITDA, the aforementioned spike in the adjusted effective tax rate, and slightly higher equity-based compensation.
Guidance
Stable. Q2 revenue of $3.86B tracks well against this target, especially given the strong 11% YoY momentum in the Americas.
Stable/At Risk. H1 2026 Adjusted EBITDA is $430M. Achieving the remaining $450M in H2 requires avoiding further margin deterioration in Asia and successfully navigating the $90M cash flow reversal expected in Q3.
Key Questions
Asia Long-Term Margin Profile
With Asia margins dropping 310 bps YoY to 12.5%, what is the structural margin floor for the domestic Chinese OEM business, and can volume growth offset this margin cannibalization?
The $90M Cash Flow Reversal
Given the footnote highlighting a $90M benefit in Q2 from commercial/derivative transactions reversing in Q3, are there any structural changes to the full-year $125M FCF target?
EMEA Restructuring ROI
EMEA margins compressed to 3.5% this quarter despite years of heavy cash restructuring outlays. At what point does management reconsider the footprint rather than just restructuring it?